产品标题 产品货号 产品规格 厂家
Human RNA: Colon: right; Colitis, ulcerative, chronic active from ORIGENE TECHNOLOGIESCR5620775 ugORIGENE TECHNOLOGIES
Human RNA: Colon: right; Colitis, ulcerative, chronic active from ORIGENE TECHNOLOGIESCR5621805 ugORIGENE TECHNOLOGIES
Human RNA: Colon: right; Crohns disease from ORIGENE TECHNOLOGIESCR5611025 ugORIGENE TECHNOLOGIES
Human RNA: Colon: right, normal from ORIGENE TECHNOLOGIESCR5591135 ugORIGENE TECHNOLOGIES
Human RNA: Colon: right, normal from ORIGENE TECHNOLOGIESCR5593405 ugORIGENE TECHNOLOGIES
Human RNA: Colon: right, normal from ORIGENE TECHNOLOGIESCR5594025 ugORIGENE TECHNOLOGIES
Human RNA: Colon: right, normal from ORIGENE TECHNOLOGIESCR5594585 ugORIGENE TECHNOLOGIES
Human RNA: Colon: right, normal from ORIGENE TECHNOLOGIESCR5595625 ugORIGENE TECHNOLOGIES
Human RNA: Colon: right, normal from ORIGENE TECHNOLOGIESCR5600215 ugORIGENE TECHNOLOGIES
Human RNA: Colon: right, normal from ORIGENE TECHNOLOGIESCR5602675 ugORIGENE TECHNOLOGIES
Human RNA: Colon: right, normal from ORIGENE TECHNOLOGIESCR5603665 ugORIGENE TECHNOLOGIES
Human Breast; Papilloma of breast from ORIGENE TECHNOLOGIESCS6062965x5umORIGENE TECHNOLOGIES
Human Breast; Papilloma of breast from ORIGENE TECHNOLOGIESCS6288085x5umORIGENE TECHNOLOGIES
Human Breast; Papilloma of breast from ORIGENE TECHNOLOGIESCS6288105x5umORIGENE TECHNOLOGIES
Human Breast; Papilloma of breast from ORIGENE TECHNOLOGIESCS6340975x5umORIGENE TECHNOLOGIES
Human Breast; Papilloma of breast from ORIGENE TECHNOLOGIESCS6366395x5umORIGENE TECHNOLOGIES
Human Breast; Radiation effect from ORIGENE TECHNOLOGIESCS7165195x5umORIGENE TECHNOLOGIES
Human Breast, right; Adenocarcinoma of breast from ORIGENE TECHNOLOGIESCS8105805x5umORIGENE TECHNOLOGIES
Human Breast, right; Adenocarcinoma of breast from ORIGENE TECHNOLOGIESCS8105815x5umORIGENE TECHNOLOGIES
Human Breast, right; Adenocarcinoma of breast from ORIGENE TECHNOLOGIESCS8105945x5umORIGENE TECHNOLOGIES
Human RNA: Colon: right; Adenoma of colon from ORIGENE TECHNOLOGIESCR5608315 ugORIGENE TECHNOLOGIES
Human Breast, right; Adenocarcinoma of breast from ORIGENE TECHNOLOGIESCS5580335x5umORIGENE TECHNOLOGIES
Human Breast, right; Adenocarcinoma of breast from ORIGENE TECHNOLOGIESCS6376595x5umORIGENE TECHNOLOGIES
Human Breast, right; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIESCS8150765x5umORIGENE TECHNOLOGIES
Human Breast, right; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIESCS5532075x5umORIGENE TECHNOLOGIES
Human Breast, right; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIESCS5560435x5umORIGENE TECHNOLOGIES
Human Breast, right; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIESCS6516755x5umORIGENE TECHNOLOGIES
Human Breast, right; Adenocarcinoma of breast, ductal, inflammatory (HER2+) from ORIGENE TECHNOLOGIESCS6013355x5umORIGENE TECHNOLOGIES
Human Breast, right; Adenocarcinoma of breast, ductal, lobular features from ORIGENE TECHNOLOGIESCS5535115x5umORIGENE TECHNOLOGIES
Human Breast, right; Adenocarcinoma of breast, ductal, metastatic from ORIGENE TECHNOLOGIESCS5525695x5umORIGENE TECHNOLOGIES
Human Breast, right; Adenocarcinoma of breast, ductal, mucinous from ORIGENE TECHNOLOGIESCS6500845x5umORIGENE TECHNOLOGIES
Human Breast, right; Adenocarcinoma of breast, ductal, recurrent from ORIGENE TECHNOLOGIESCS5548505x5umORIGENE TECHNOLOGIES
Human Breast, right; Adenocarcinoma of breast, ductal, recurrent from ORIGENE TECHNOLOGIESCS6326555x5umORIGENE TECHNOLOGIES
Human Breast, right; Adenocarcinoma of breast, lobular from ORIGENE TECHNOLOGIESCS7117145x5umORIGENE TECHNOLOGIES
Human Breast, right; Adenocarcinoma of breast, lobular from ORIGENE TECHNOLOGIESCS7155955x5umORIGENE TECHNOLOGIES
Human Breast, right; Adenocarcinoma of breast, lobular from ORIGENE TECHNOLOGIESCS6503075x5umORIGENE TECHNOLOGIES
Human Breast, right; Adenocarcinoma of breast, lobular from ORIGENE TECHNOLOGIESCS6518415x5umORIGENE TECHNOLOGIES
Human Breast, right; Biopsy site changes from ORIGENE TECHNOLOGIESCS7154405x5umORIGENE TECHNOLOGIES
Human Breast, right; Biopsy site changes from ORIGENE TECHNOLOGIESCS7155975x5umORIGENE TECHNOLOGIES
Human Breast, right; Carcinoma in situ of breast, ductal from ORIGENE TECHNOLOGIESCS8045705x5umORIGENE TECHNOLOGIES
Human Breast, right; Carcinoma in situ of breast, ductal from ORIGENE TECHNOLOGIESCS5527215x5umORIGENE TECHNOLOGIES
Human Breast, right; Carcinoma of breast, adenoid cystic from ORIGENE TECHNOLOGIESCS5278295x5umORIGENE TECHNOLOGIES
Human Breast, right; Ductal hyperplasia of breast from ORIGENE TECHNOLOGIESCS5459625x5umORIGENE TECHNOLOGIES
Human Breast, right; Ductal hyperplasia of breast from ORIGENE TECHNOLOGIESCS5525785x5umORIGENE TECHNOLOGIES
Human Breast, right; Fibrocystic breast disease from ORIGENE TECHNOLOGIESCS7152965x5umORIGENE TECHNOLOGIES
Human Breast, right; Fibrocystic breast disease from ORIGENE TECHNOLOGIESCS7154395x5umORIGENE TECHNOLOGIES
Human Breast, right; Fibrocystic breast disease from ORIGENE TECHNOLOGIESCS8100055x5umORIGENE TECHNOLOGIES
Human Breast, right; Fibrocystic changes of breast, atypical from ORIGENE TECHNOLOGIESCS7126925x5umORIGENE TECHNOLOGIES
Human Breast, right; Fibrocystic changes to breast from ORIGENE TECHNOLOGIESCS7126875x5umORIGENE TECHNOLOGIES
Human Breast, right; Fibrocystic changes to breast from ORIGENE TECHNOLOGIESCS7126885x5umORIGENE TECHNOLOGIES
 |< < 2260 2261 2262 2263 2264 2265 2266 2267 2268 > >| 第 2267/6274 页